Skip to main content

Week Five Progress

During week five, more research was done and the group was able to decide on the exact concentrations of calcium chloride to use in making each hydrogel layer as well as in the beads. The higher the concentration of calcium chloride, the more dense the hydrogel layer will be. Thus, for the thin, low-density layer, as well as for the low-density beads, a 5% calcium chloride solution will be used. For the thick, high-density layer, a 7% calcium chloride solution will be used. Refer to Figure 1, below, for a visual of the design.


Figure 1: Preliminary Diagram of the Hydrogel Wound Dressing 



Another task that was completed this week was additional planning for the testing phase. Once the hydrogel has been constructed, samples of it will be placed into cuvettes, and fluorescently-labeled bovine serum albumin (FITC-BSA) will be injected into the cuvettes, one at a time, in intervals of four hours. This will occur over a period of two days, and at the end of the two days, these samples will be brought to the lab and their absorbances will be measured. The absorbance value will be measured at a wavelength of 280 nm. This wavelength is shown below in Figure 2 as the second optimal wavelength at which to measure the absorbance. The absorbance cannot be measured at a wavelength of 495 nm, because FITC-BSA loses its fluorescence too quickly for our purposes when exposed to light at this wavelength.
Figure 2: Absorbance Spectrum of FITC-BSA [1]


Upon measuring the wavelength of each of the samples, the concentration of dye that has seeped through each sample will be calculated using the absorbance value and the standard curve, pictured below in Figure 3. This will give an indication of the amount of therapeutic that could seep through the hydrogel in that amount of time.
Figure 3: Standard Curve of Concentration vs. Absorbance for FITC-BSA [2]


References:
[1] N. Barbero, C. B., and G. Viscardi, UV-Vis spectrum of the BSA bioconjugated with FITC. 2016.
[2] R. J. Rivers, J. B. Beckman, and M. D. S. Frame, absorbance versus dye concentration curve of FITC-BSA. Journal of the American Society of Anesthesiologists, 2001.

Comments

Post a Comment

Popular posts from this blog

Week Nine Progress

The progress underwent during week nine of the hydrogel restructuring module entailed rectifying the errors made during the first and second testing rounds conducted during week seven. The results of first and second testing trials revealed egregious errors upon obtaining the results of the spectrophotometry of week eight. The spectrophotometry results delineated a consistent decrease in fluorescent intensity over time. Nonetheless, an ideal graph would illustrate a sustained increase in fluorescent intensity, thereby paralleling an increase in the percentage of therapeutic that is released. The increase in fluorescent intensity which had resulted from the week seven testing may be attributed to the experimental errors which occurred during the construction of hydrogel samples, and are described in full detail in the Week Eight Progress Report.  During week nine, new hydrogel samples were generated in a comparable fashion to the construction of samples during the second phase of t...
Post a Comment
Read more

Week Three Progress

During Week Three, we discussed and determined our therapeutic agent for the hydrogel module. After extensive research and comparison of our options, we decided the best-suited therapeutic would be zinc oxide. This substance fits our design so well because it is hydrophobic and will slowly disperse through the pores in the bottom hydrogel layer. Zinc oxide has been used in past hydrogel models and has been proven to be effective. It is an agent that has been used in ointments and supplements to treat burns and prevent infections. Likewise, the possibility of overdosing on zinc-oxide necessitates a solution for controlled therapeutic release. The predominant delivery system for zinc oxide is through medicinal cream, the delivery through which enables the therapeutic threshold of zinc oxide to be increased to levels of high toxicity. Symptoms of zinc-oxide overdose include: fever, chills, vomiting, mouth irritation, stomach pain, and yellowing of the eyes and skin. Consequently, the phar...
Post a Comment
Read more

Week Two Progress

The objectives of the week two lab consisted of preparing for the construction of the therapeutic-infused hydrogel adhesive. As such, a bill of materials was devised to determine the requisite laboratory supplies. It was determined that chemical components and laboratory glassware would be required to conduct the precipitation reaction between calcium chloride and sodium alginate. As the therapeutic agent, to be injected into the hydrogel 'beads', has not yet been determined, a comparable placebo had not been established. Nonetheless, each team member is to conduct research to determine an appropriate therapeutic for the hydrogel adhesive before a comparable placebo may be determined. Research regarding a possible therapeutic agent is to be completed before the week three lab. Once a therapeutic agent is agreed upon, a placebo, of comparable physical properties, will be ordered. The week two activities were completed in preparation for the construction of a preliminary design ...
Post a Comment
Read more